SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-293352
Filing Date
2015-08-17
Accepted
2015-08-17 17:09:15
Documents
14
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d943604d10q.htm 10-Q 820969
2 EX-10.1 d943604dex101.htm EX-10.1 90573
3 EX-10.2 d943604dex102.htm EX-10.2 56007
4 EX-10.3 d943604dex103.htm EX-10.3 15969
5 EX-31.1 d943604dex311.htm EX-31.1 7219
6 EX-31.2 d943604dex312.htm EX-31.2 7223
7 EX-32.1 d943604dex321.htm EX-32.1 3849
8 EX-32.2 d943604dex322.htm EX-32.2 3922
  Complete submission text file 0001193125-15-293352.txt   4226985

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aegr-20150630.xml EX-101.INS 625284
10 XBRL TAXONOMY EXTENSION SCHEMA aegr-20150630.xsd EX-101.SCH 42491
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20150630_cal.xml EX-101.CAL 74562
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20150630_def.xml EX-101.DEF 150335
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20150630_lab.xml EX-101.LAB 375427
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20150630_pre.xml EX-101.PRE 281566
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 151059529
SIC: 2834 Pharmaceutical Preparations